Modified Valsalva Manoeuvre Effectively Treats Supraventricular Tachycardia In Adults
- byDoctor News Daily Team
 - 14 July, 2025
 - 0 Comments
 - 0 Mins
 
                            
                                    Cardiac arrhythmia, specifically paroxysmal supraventricular tachycardia (SVT), accounts for a substantial proportion of emergency medical services resources utilisation. Reconversion requires increasing the atrioventricular node's refractoriness, which can be achieved by vagal manoeuvres, pharmacological agents or electrical cardioversion.
There are multiple variants of vagal manoeuvres, including the Valsalva manoeuvre (VM). While the effectiveness of the standard Valsalva manoeuvre has already been systematically reviewed, there has been no such analysis for the modified Valsalva manoeuvre.
Recently, a report published in the European Journal of Emergency Medicine has stated that modified Valsalva manoeuvre has been more effective when compared to standard Valsalva manoeuvre in treating patients with supraventricular tachycardia.
Lodewyckx, Eric and colleagues from the Department of PXL-Healthcare, PXL University of Applied Sciences and Arts compared the effectiveness of the modified Valsalva manoeuvre versus the standard Valsalva manoeuvre in restoring the normal sinus rhythm in adult patients with supraventricular tachycardia.
The primary outcome was the reconversion to a sinus rhythm. Secondary outcomes included medication use, adverse events, length of stay in the emergency department and hospital admission.
Five randomised controlled trials were included, with a combined total of 1181 participants. The meta-analysis demonstrated a significantly higher success rate for reconversion to sinus rhythm when using the modified Valsalva manoeuvre compared to the standard Valsalva manoeuvre in patients with an supraventricular tachycardia. More adverse events were reported in the modified Valsalva manoeuvre group, although this difference is NS.
The available evidence suggests that medication use was lower in the modified Valsalva manoeuvre group than the standard Valsalva manoeuvre group. However, medication use could not be generalised across the different studies.
None of the included studies showed a significant difference in length of stay in the emergency department. Only one study reported on hospital admission, with no significant difference between the two groups.
The authors concluded that the available evidence is highly suggestive to support the use of the modified Valsalva manoeuvre compared to the standard Valsalva manoeuvre in the treatment of adult patients with supraventricular tachycardia.
Furthermore, meta-analysis showed a higher success rate, required less medication use, and resulted in an equal number of adverse events. However, these results cannot be regarded as definitive in the absence of higher-quality studies.
doi: 10.1097/MEJ.0000000000000862
                                
    Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
    The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
    Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
    If you come across any inconsistencies, please reach out to us at 
    admin@doctornewsdaily.com.
    We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
    By using this website, you agree to our 
    Terms of Use, 
    Privacy Policy, and 
    Advertisement Policy.
    For further details, please review our 
    Full Disclaimer.
Recent News
Gum disease could silently cause serious brain dam...
- 03 November, 2025
 
Can Early-Day Fasting Significantly Boost Metaboli...
- 03 November, 2025
 
Delhi HC bars doctor from running medical centre d...
- 03 November, 2025
 
Phase III data for Gazyva/Gazyvaro show significan...
- 03 November, 2025
 
Daily Newsletter
Get all the top stories from Blogs to keep track.
                    
                    
0 Comments
Post a comment
No comments yet. Be the first to comment!